154 related articles for article (PubMed ID: 10613451)
1. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma.
Matsushita K; Matsumoto T; Ohtsubo H; Fujiwara H; Imamura N; Hidaka S; Kukita T; Tei C; Matsumoto M; Arima N
Leuk Lymphoma; 1999 Dec; 36(1-2):67-75. PubMed ID: 10613451
[TBL] [Abstract][Full Text] [Related]
2. Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).
Tsukasaki K; Tobinai K; Shimoyama M; Kozuru M; Uike N; Yamada Y; Tomonaga M; Araki K; Kasai M; Takatsuki K; Tara M; Mikuni C; Hotta T;
Int J Hematol; 2003 Feb; 77(2):164-70. PubMed ID: 12627852
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
4. [An intensive chemotherapy of adult T-cell leukemia/lymphoma].
Taguchi H
Rinsho Ketsueki; 1996 Aug; 37(8):654-60. PubMed ID: 8827873
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study.
Tsukamoto Y; Kiyasu J; Choi I; Kozuru M; Uike N; Utsunomiya H; Hirata A; Fujioka E; Ohno H; Nakashima E; Nakashima Y; Miyashita K; Tachikawa Y; Narazaki T; Tsuda M; Haji S; Takamatsu A; Tanaka E; Goto T; Takatsuki H; Oyama M; Muta H; Yagi Y; Ikeda M; Matsushima T; Yufu Y; Suehiro Y
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e445-e453. PubMed ID: 32312633
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
[TBL] [Abstract][Full Text] [Related]
7. EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.
Toriyama E; Imaizumi Y; Taniguchi H; Taguchi J; Nakashima J; Itonaga H; Sato S; Ando K; Sawayama Y; Hata T; Fukushima T; Miyazaki Y
Int J Hematol; 2018 Aug; 108(2):167-175. PubMed ID: 29651666
[TBL] [Abstract][Full Text] [Related]
8. [EPOCH therapy for relapsed/refractory lymphoid malignancies].
Dobashi N; Usui N; Kobayashi T; Yamazaki H; Asai O; Yano S; Kato A; Watanabe H; Nagamine M; Katori M; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Apr; 39(4):267-72. PubMed ID: 9597893
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
11. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Sweetenham JW; Mead GM; Whitehouse JM
J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
[TBL] [Abstract][Full Text] [Related]
12. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
[TBL] [Abstract][Full Text] [Related]
13. Adult T-cell leukemia-lymphoma.
Tsukasaki K
Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
[TBL] [Abstract][Full Text] [Related]
14. [Successful chronic daily administration of oral etoposide for a case of adult T cell leukemia].
Matsuoka H; Toyama T; Horinouchi M; Maeda K; Suzuki M; Kubuki Y; Komura K; Ishikawa T; Uno H; Tsubouchi H
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1387-90. PubMed ID: 8346938
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience.
Makiyama J; Imaizumi Y; Tsushima H; Taniguchi H; Moriwaki Y; Sawayama Y; Imanishi D; Taguchi J; Hata T; Tsukasaki K; Miyazaki Y
Int J Hematol; 2014 Nov; 100(5):464-72. PubMed ID: 25209605
[TBL] [Abstract][Full Text] [Related]
16. [Adult T-cell leukemia/lymphoma of bone with multiple pathological fractures].
Yamamoto Y; Ishii K; Nomura S; Fukuhara S
Rinsho Ketsueki; 2004 Mar; 45(3):247-9. PubMed ID: 15103941
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia.
Uozumi K; Hanada S; Ohno N; Ishitsuka K; Shimotakahara S; Otsuka M; Chyuman Y; Nakahara K; Takeshita T; Kuwazuru Y
Leuk Lymphoma; 1995 Jul; 18(3-4):317-23. PubMed ID: 8535199
[TBL] [Abstract][Full Text] [Related]
18. Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
Besson C; Panelatti G; Delaunay C; Gonin C; Brebion A; Hermine O; Plumelle Y
Leuk Lymphoma; 2002 Dec; 43(12):2275-9. PubMed ID: 12613513
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Sakamoto Y; Ishida T; Masaki A; Murase T; Takeshita M; Muto R; Iwasaki H; Ito A; Kusumoto S; Nakano N; Tokunaga M; Yonekura K; Tashiro Y; Iida S; Utsunomiya A; Ueda R; Inagaki H
Br J Haematol; 2021 Nov; 195(4):571-584. PubMed ID: 34405395
[TBL] [Abstract][Full Text] [Related]
20. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Lee KW; Yun T; Kim DW; Im SA; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
Leuk Lymphoma; 2006 Jul; 47(7):1274-82. PubMed ID: 16923557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
